{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:45:25Z","timestamp":1767015925907},"reference-count":38,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Children, adolescents, and young adults receiving intensive chemotherapy for acute myeloid leukemia or high-risk or relapsed acute lymphoblastic leukemia sustain prolonged periods of neutropenia that predispose them to invasive fungal disease (IFD). For many decades the standard of care for these patients was to initiate empirical antifungal therapy after a period of prolonged fever and neutropenia. Recent publications have yielded important evidence on the utility of different diagnostic and therapeutic approaches aimed at reducing the impact of IFD among these patients during these vulnerable periods. This case-based review highlights and interprets the published data to provide context for the IFD diagnostic and therapeutic recommendations proposed in multiple published guidelines. Personalized approaches are offered at points where evidence is lacking. Time points where specific knowledge gaps exist are identified along the clinical trajectory of the prolonged neutropenic period to illustrate areas for future investigation.<\/jats:p>","DOI":"10.1182\/hematology.2021000267","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T12:13:03Z","timestamp":1639138383000},"page":"361-367","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Fungal diagnostic testing and therapy: navigating the neutropenic period in children with high-risk leukemia"],"prefix":"10.1182","volume":"2021","author":[{"given":"Brian T.","family":"Fisher","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA; and Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"issue":"10","key":"2021121012071895600_hem2021000267C1","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1182\/blood-2007-05-091942","article-title":"Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia","volume":"110","author":"Sung","year":"2007","journal-title":"Blood"},{"issue":"17","key":"2021121012071895600_hem2021000267C2","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/jama.2019.15702","article-title":"Effect of caspofungin vs fluconazole prophylaxis on invasive fungal disease among children and young adults with acute myeloid leukemia: a randomized clinical trial","volume":"322","author":"Fisher","year":"2019","journal-title":"JAMA"},{"issue":"6","key":"2021121012071895600_hem2021000267C3","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2021121012071895600_hem2021000267C4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.mph.0000155861.38641.ca","article-title":"Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution","volume":"27","author":"Rosen","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"2021121012071895600_hem2021000267C5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1096-911X(200005)34:5<313::AID-MPO1>3.0.CO;2-Q","article-title":"Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia","volume":"34","author":"Leahey","year":"2000","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"2021121012071895600_hem2021000267C6","doi-asserted-by":"crossref","first-page":"e28035","DOI":"10.1002\/pbc.28035","article-title":"Comment on: invasive fungal infections in children with acute lymphoblastic leukemia","volume":"67","author":"Castagnola","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"2021121012071895600_hem2021000267C7","doi-asserted-by":"crossref","first-page":"e27915","DOI":"10.1002\/pbc.27915","article-title":"Invasive fungal infections in children with acute lymphoblastic leukaemia: results from four Australian centres, 2003-2013","volume":"66","author":"Wang","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"2021121012071895600_hem2021000267C8","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2021121012071895600_hem2021000267C9","doi-asserted-by":"crossref","first-page":"e1286","DOI":"10.1542\/peds.2007-2117","article-title":"Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases","volume":"121","author":"Burgos","year":"2008","journal-title":"Pediatrics"},{"issue":"4","key":"2021121012071895600_hem2021000267C10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jpids\/piu074","article-title":"A prospective, international cohort study of invasive mold infections in children","volume":"4","author":"Wattier","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"3","key":"2021121012071895600_hem2021000267C11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jpids\/pix030","article-title":"Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review","volume":"7","author":"Fisher","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"10","key":"2021121012071895600_hem2021000267C12","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"2021121012071895600_hem2021000267C13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/myc.12063","article-title":"Invasive fungal infections in paediatric acute myeloid leukaemia","volume":"56","author":"Johnston","year":"2013","journal-title":"Mycoses"},{"issue":"3","key":"2021121012071895600_hem2021000267C14","first-page":"174","article-title":"Invasive fungal infection in children with persistent febrile neutropenia","volume":"104","author":"Lai","year":"2005","journal-title":"J Formos Med Assoc"},{"issue":"10","key":"2021121012071895600_hem2021000267C15","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/cncr.27957","article-title":"Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States","volume":"119","author":"Kavcic","year":"2013","journal-title":"Cancer"},{"issue":"3","key":"2021121012071895600_hem2021000267C16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood.2019001557","article-title":"How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children","volume":"135","author":"Teachey","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2021121012071895600_hem2021000267C17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"Am J Med"},{"issue":"1","key":"2021121012071895600_hem2021000267C18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2141.2009.07844.x","article-title":"International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia","volume":"147","author":"Lehrnbecher","year":"2009","journal-title":"Br J Haematol"},{"issue":"4","key":"2021121012071895600_hem2021000267C19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"2021121012071895600_hem2021000267C20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/cid\/cit781","article-title":"Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia","volume":"58","author":"Fisher","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"27","key":"2021121012071895600_hem2021000267C21","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1200\/JCO.20.00158","article-title":"Clinical practice guideline for systemic antifungal prophylaxis in pediatric patients with cancer and hematopoietic stem-cell transplantation recipients","volume":"38","author":"Lehrnbecher","year":"2020","journal-title":"J Clin Oncol"},{"issue":"6","key":"2021121012071895600_hem2021000267C22","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood.V97.6.1604","article-title":"Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation","volume":"97","author":"Maertens","year":"2001","journal-title":"Blood"},{"issue":"2","key":"2021121012071895600_hem2021000267C23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/421944","article-title":"Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome","volume":"39","author":"Odabasi","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2021121012071895600_hem2021000267C24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/CVI.00025-07","article-title":"Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting","volume":"14","author":"Smith","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"2021121012071895600_hem2021000267C25","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/cid\/ciw592","article-title":"Galactomannan, \u03b2-D-glucan, and polymerase chain reaction-based assays for the diagnosis of invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"63","author":"Lehrnbecher","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2021121012071895600_hem2021000267C26","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/jpids\/piab036","article-title":"Prospective evaluation of galactomannan and (1\u200a\u2192\u200a3) \u03b2-d-glucan assays as diagnostic tools for invasive fungal disease in children, adolescents, and young adults with acute myeloid leukemia receiving fungal prophylaxis","volume":"10","author":"Fisher","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"7","key":"2021121012071895600_hem2021000267C27","doi-asserted-by":"crossref","first-page":"e27734","DOI":"10.1002\/pbc.27734","article-title":"Cell-free DNA next-generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease","volume":"66","author":"Armstrong","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"15","key":"2021121012071895600_hem2021000267C28","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.ejca.2008.06.040","article-title":"Empirical antifungal therapy for patients with neutropenia and persistent fever: systematic review and meta-analysis","volume":"44","author":"Goldberg","year":"2008","journal-title":"Eur J Cancer"},{"issue":"18","key":"2021121012071895600_hem2021000267C29","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"issue":"8","key":"2021121012071895600_hem2021000267C30","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2021121012071895600_hem2021000267C31","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/jac\/dky244","article-title":"Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial","volume":"73","author":"Santolaya","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2021121012071895600_hem2021000267C32","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Groll","year":"2021","journal-title":"Lancet Oncol"},{"issue":"12","key":"2021121012071895600_hem2021000267C33","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2021121012071895600_hem2021000267C34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/pbc.20717","article-title":"Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders","volume":"48","author":"Hovi","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"2021121012071895600_hem2021000267C35","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/INF.0b013e3180616cbb","article-title":"Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients","volume":"26","author":"Steinbach","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"2021121012071895600_hem2021000267C36","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/INF.0b013e31817197ab","article-title":"Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis","volume":"27","author":"Hayden","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2021121012071895600_hem2021000267C37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3855\/jidc.2110","article-title":"Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients","volume":"6","author":"Badiee","year":"2012","journal-title":"J Infect Dev Ctries"},{"issue":"8","key":"2021121012071895600_hem2021000267C38","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1128\/JCM.00747-15","article-title":"\u03b2-D-glucan screening for detection of invasive fungal disease in children undergoing allogeneic hematopoietic stem cell transplantation","volume":"53","author":"Koltze","year":"2015","journal-title":"J Clin Microbiol"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2021\/1\/361\/1851411\/361fisher.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2021\/1\/361\/1851411\/361fisher.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T22:51:37Z","timestamp":1699915897000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2021\/1\/361\/483013\/Fungal-diagnostic-testing-and-therapy-navigating"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,10]]},"published-print":{"date-parts":[[2021,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2021000267","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,10]]},"published":{"date-parts":[[2021,12,10]]}}}